Cargando…
Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
BACKGROUND: Higher fibroblast growth factor‐23 (FGF‐23) levels are associated with incident heart failure (HF) in MESA (the Multiethnic Study of Atherosclerosis). FGF‐23 is also associated with left ventricular hypertrophy. Whether the FGF‐23 association with HF is similar for heart failure with red...
Autores principales: | Almahmoud, Mohamed Faher, Soliman, Elsayed Z., Bertoni, Alain G., Kestenbaum, Bryan, Katz, Ronit, Lima, João A. C., Ouyang, Pamela, Miller, P. Elliott, Michos, Erin D., Herrington, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222949/ https://www.ncbi.nlm.nih.gov/pubmed/30371180 http://dx.doi.org/10.1161/JAHA.117.008334 |
Ejemplares similares
-
Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
por: Roy, Clotilde, et al.
Publicado: (2020) -
Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
por: Kanagala, Prathap, et al.
Publicado: (2020) -
Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Duprez, Daniel A., et al.
Publicado: (2018) -
Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi‐Ethnic Study of Atherosclerosis
por: O'Neal, Wesley T., et al.
Publicado: (2017) -
Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)